Vivanza Biosciences Ltd
Market Capital : 8.80 Cr.
P/E Ratio : -98.65
P/B Ratio : 5.86
Book Value Per Share : 1.16
EPS : 0.14
Dividend Yield : 0.00 %
Revenue Growth : -77.13 %
Profit Growth : -8.52 %
Market Capital : 8.80 Cr.
P/E Ratio : -98.65
P/B Ratio : 5.86
Book Value Per Share : 1.16
EPS : 0.14
Dividend Yield : 0.00 %
Revenue Growth : -77.13 %
Profit Growth : -8.52 %
Strengths
Weaknesses
| COMPANY NAME | CURRENT PRICE | PE RATIO | REVENUE GROWTH | PROFIT GROWTH |
|---|---|---|---|---|
|
₹1,829 |
38.36 |
10.46% |
13.01% |
|
|
₹1,526 |
24.69 |
7.10% |
47.10% |
|
|
₹1,183 |
18.38 |
15.81% |
23.75% |
|
|
₹6,104 |
78.39 |
25.01% |
-12.25% |
|
|
₹3,255 |
59.17 |
2.82% |
33.02% |
|
|
₹2,386 |
48.22 |
23.90% |
49.23% |
|
|
₹1,100 |
25.63 |
20.78% |
96.88% |
|
|
₹2,036 |
32.4 |
10.97% |
345.15% |
As per the National Stock Exchange, Vivanza Biosciences Ltd’s ticker symbol is "VIVANZA".
The Vivanza Biosciences Ltd’s market capitalization is ₹ 8.8 Cr.
As of now, Vivanza Biosciences Ltd has a market capitalization of ₹8.8 Cr, making it a small-cap company. These companies are typically in the early stages of growth and have the potential for high returns, but they come with higher risk and more volatility. If you're okay with more risk and want the chance for bigger rewards, investing in small-cap companies like Vivanza Biosciences Ltd could be a good option.
Stop guessing and start calculating.
Disclaimer: The financial blogs and tools provided on this website are for informational purposes only. We do not constitute financial advice, and the accuracy or completeness of the information cannot be guaranteed. Users are encouraged to conduct their own research and seek professional financial advice before making any investment decisions.
